Stephan Clasen
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma
Mehra T, Naumann A, Clasen S, Dummer R, Claussen C, Röcken M, Moos R, Guenova E, Mann S, Grözinger G, Garbe C. Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma. PloS one 2014; 9:e112535.
Nov 10, 2014Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma
Nov 10, 2014PloS one 2014; 9:e112535
Mehra Tarun, Naumann Aline, Clasen Stephan, Dummer Reinhard, Claussen Claus Detlef, Röcken Martin, Moos Rudolf, Guenova Emmanuella, Mann Steven, Grözinger Gerd, Garbe Claus
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients
Meier F, Garbe C, Knaudt B, Zielinski C, Leiter U, Forschner A, Eigentler T, Clasen S, Guenova E, Berneburg M. Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients. J Am Acad Dermatol 2009; 60:863-8.
May 1, 2009Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients
May 1, 2009J Am Acad Dermatol 2009; 60:863-8
Meier Friedegund, Garbe Claus, Knaudt Björn, Zielinski Christina, Leiter Ulrike, Forschner Andrea, Eigentler Thomas, Clasen Stephan, Guenova Emmanuella, Berneburg Mark